Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature

Anna Roux,Daniela Rosso,Daniela Cuboni,Mauro Maccario,Silvia Grottoli,Emanuela Arvat,Valentina Gasco

DOI: https://doi.org/10.3390/biomedicines12061368

IF: 4.757

2024-06-20

Biomedicines

Abstract:Hypothyroidism is a frequently diagnosed endocrine disorder. Common signs and symptoms include fatigue, cold intolerance, hoarseness, dry skin, constipation, a slow relaxation phase of deep tendon reflexes, and bradycardia. However, some patients may exhibit atypical signs and symptoms, which can result in diagnostic confusion. Pituitary hyperplasia resulting from longstanding primary hypothyroidism was first described by Niepce in 1851. It is usually asymptomatic, but sometimes, in addition to symptoms of overt hypothyroidism, patients may complain of headaches, hypopituitarism, visual field impairment, and hyperprolactinemia. Furthermore, on imaging, pituitary hyperplasia can be mistaken for a pituitary adenoma. Distinguishing between the two is crucial, as their management differs; the former often responds to thyroid hormone replacement therapy, while the latter might need treatment with surgery and/or radiotherapy. Here we describe a patient who developed pituitary hyperplasia in the setting of longstanding uncompensated primary hypothyroidism due to a lack of compliance with levothyroxine replacement therapy. We also review the clinical, laboratory, and radiologic findings of the case reports available in the literature up to now in order to improve the knowledge and the care of the disease.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

This paper aims to address the issue of pituitary hyperplasia caused by long - term uncontrolled primary hypothyroidism (PH). Specifically, through a case report and literature review, the paper explores the following aspects:

1. **Diagnostic challenges**: Since the imaging manifestations of pituitary hyperplasia may be similar to those of pituitary adenomas, clinicians are likely to be confused during diagnosis. The paper emphasizes the importance of differentiating these two conditions because their treatment methods are different: pituitary hyperplasia usually responds well to thyroid hormone replacement therapy, while pituitary adenomas may require surgery or radiotherapy.

2. **Clinical features**: The paper details the main symptoms of the patient, including headache, visual impairment, hypothyroidism symptoms (such as fatigue, weight gain, constipation, etc.), irregular menstruation, and hyperprolactinemia. In addition, some rare symptoms are also mentioned, such as ovarian hyperstimulation syndrome, psychosis, and acromegaly.

3. **Treatment efficacy**: Through case reports and literature reviews, the paper shows the good efficacy of thyroid hormone replacement therapy (mainly levothyroxine) for pituitary hyperplasia. In most patients, pituitary lesions significantly shrink or completely disappear after treatment.

4. **Risk of misdiagnosis**: The paper points out that although thyroid hormone replacement therapy is effective for pituitary hyperplasia, a considerable proportion of patients are still misdiagnosed as having pituitary adenomas and receive unnecessary neurosurgical operations, which may lead to irreversible damage, especially in young patients.

5. **Rare cases**: Although pituitary hyperplasia responds well to thyroid hormone replacement therapy, there are also a few cases showing no response to treatment. In these cases, the possibility of non - functional pituitary adenomas, prolactin - secreting pituitary adenomas, or thyroid - stimulating hormone - secreting pituitary adenomas needs to be considered.

Through the exploration of these aspects, the paper aims to improve clinicians' understanding of pituitary hyperplasia, reduce misdiagnosis and unnecessary surgical interventions, and thus improve patients' treatment outcomes and quality of life.